跳至主要内容
临床试验/CTRI/2026/04/107362
CTRI/2026/04/107362尚未招募不适用

Effect of oats containing ß-glucan supplementation on glycemic control in Indian adults with type 2 diabetes.

Lisa sarkar self1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2026年4月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
140
试验地点
1

研究概览

简要总结

This is a randomised controlled parallel group trial on the effect of oats containing beta-glucan in 140 Indian diabetic patients. The primary outcome is to measure the changes in HbA1c from baseline to 12 weeks of the intervention.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age 20 to 60 years.
  • Diagnosed with type 2 diabetes for more than 6 months.
  • On stable antidiabetic drug regimen and no change for more than 6 months Baseline HbA1c 7 to 10 per cent BMI greater than 23 kg per meter square.
  • According to the Endocrine Society of India, a BMI greater than 23 is considered overweight, and a BMI greater than 25 is considered obesity.
  • Patient giving informed consent.

排除标准

  • Use of any extra supplement like psyllium or viscous fiber within 4 weeks.
  • Significant renal eGFR less than 45, chronic liver disease, recent cardiovascular events, pregnancy and lactation.
  • Any known history of GI malabsorption, inflammatory bowel disease .
  • Known intolerance of oats or barley Patient refuses to give consent.

研究者

发起方
Lisa sarkar self
申办方类型
Other [Sister Nivedita University private university]
责任方
Principal Investigator
主要研究者

Lisa Sarkar

Sister Nivedita University

研究点 (1)

Loading locations...

相似试验